These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 22418058

  • 1. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
    Hamilton A, Holscher C.
    Brain Res; 2012 Apr 17; 1449():83-93. PubMed ID: 22418058
    [Abstract] [Full Text] [Related]

  • 2. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
    Tang J, Song M, Wang Y, Fan X, Xu H, Bai Y.
    Biochem Biophys Res Commun; 2009 Jul 31; 385(3):341-5. PubMed ID: 19463786
    [Abstract] [Full Text] [Related]

  • 3. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug 31; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 4. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC, Lee SH, Lee DW, Kim SY, Kim GY, Rhim HS, Choi CB, Kim HY, Lee CU, Choe BY.
    Behav Brain Res; 2010 Jul 29; 211(1):125-31. PubMed ID: 20307581
    [Abstract] [Full Text] [Related]

  • 5. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL, Hölscher C.
    Neuropharmacology; 2014 Jan 29; 76 Pt A():57-67. PubMed ID: 23973293
    [Abstract] [Full Text] [Related]

  • 6. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y, He J, Zhang Y, Luo H, Zhu S, Yang Y, Zhao T, Wu J, Huang Y, Kong J, Tan Q, Li XM.
    Hippocampus; 2009 Dec 29; 19(12):1247-53. PubMed ID: 19309037
    [Abstract] [Full Text] [Related]

  • 7. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ.
    J Comp Neurol; 2006 Mar 01; 495(1):70-83. PubMed ID: 16432899
    [Abstract] [Full Text] [Related]

  • 8. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB, Franko M, Banks WA, Kasinadhuni P, Farr SA, Vyas K, Choudhuri V, Morley JE.
    J Exp Biol; 2009 Feb 01; 212(Pt 4):494-8. PubMed ID: 19181896
    [Abstract] [Full Text] [Related]

  • 9. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM, Hölscher C.
    Neuroscience; 2013 Jan 03; 228():294-300. PubMed ID: 23103794
    [Abstract] [Full Text] [Related]

  • 10. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
    Miettinen R, Riedel A, Kalesnykas G, Kettunen HP, Puoliväli J, Soininen H, Arendt T.
    J Chem Neuroanat; 2005 Oct 03; 30(2-3):105-18. PubMed ID: 16081247
    [Abstract] [Full Text] [Related]

  • 11. Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
    Liu Y, Xu YF, Zhang L, Huang L, Yu P, Zhu H, Deng W, Qin C.
    CNS Neurosci Ther; 2017 Jul 03; 23(7):590-604. PubMed ID: 28597477
    [Abstract] [Full Text] [Related]

  • 12. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S, Wolf S, Staufenbiel M, Kempermann G.
    Hippocampus; 2009 Oct 03; 19(10):1008-18. PubMed ID: 19219917
    [Abstract] [Full Text] [Related]

  • 13. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 03; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 14. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N, Delatour B, Le Cudennec C, Guégan M, Volk A, Dhenain M.
    Neurobiol Dis; 2006 Apr 03; 22(1):199-208. PubMed ID: 16337798
    [Abstract] [Full Text] [Related]

  • 15. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B, Mørk A, Plath N, Kristiansen U, Bastlund JF.
    Behav Brain Res; 2013 Mar 01; 240():146-52. PubMed ID: 23178660
    [Abstract] [Full Text] [Related]

  • 16. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 01; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, Yin M.
    Neurosci Lett; 2013 Dec 17; 557 Pt B():84-9. PubMed ID: 24176881
    [Abstract] [Full Text] [Related]

  • 18. Presenilin 1-related alterations in DNA integrity in a transgenic mouse model of Alzheimer's disease.
    Michelsen KA, Korr H, Steinbusch HW, Schmitz C.
    Brain Res; 2010 Feb 26; 1316():139-44. PubMed ID: 20034479
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF.
    J Pharmacol Exp Ther; 2007 Aug 26; 322(2):541-9. PubMed ID: 17505020
    [Abstract] [Full Text] [Related]

  • 20. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease.
    Pérez-González R, Antequera D, Vargas T, Spuch C, Bolós M, Carro E.
    J Alzheimers Dis; 2011 Aug 26; 24 Suppl 2():17-25. PubMed ID: 21335656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.